Skip to main content

Global Endoscopic Ultrasound Market to Touch USD 1,375.6 Million with a CAGR of 6.5% by 2026; Increasing Number of Medical Professionals to Stimulate Growth: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Dec. 11, 2020 (GLOBE NEWSWIRE) — The global Endoscopic Ultrasound Market size is projected to reach USD 1,375.6 million by 2026, registering a CAGR of 6.5% during the forecast period. The market value stood at USD 830.6 Million in 2018. With a revenue generation of USD 296.9 Million in 2018, North America is set to occupy a commanding position in the EUS market till 2026.INDUSTRY DEVELOPMENT:August 2017: PENTAX Medical announced the launch of the Slim Linear Ultrasound Endoscope (EG-3270UK) in the U.S.June 2018: Olympus Corporation announced a strategic alliance with Hitachi Medical Systems Europe as a result of which Olympus’ endoscopic ultrasound sonography (EUS) scopes will now be compatible with Hitachi’s ultrasound system ARIETTA 850 ENDOSCOPIC.May 2018: Olymbus Corporation and Hitachi Healthcare Americas announced a distribution agreement in the U.S. for ARIETTA 850, an ultrasound processor.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/endoscopic-ultrasound-market-100558
Growing prevalence of gastric cancer is touted to be the key driver for the growth of this market during the forecast period. Gastric cancer or cancer of the stomach is one of the leading cancer-related deaths in the world. According to the GLOBOCAN 2018 report of the International Association of Cancer Registries (IARC), gastric cancer was the third deadly type of cancer in 2018, causing 783,000 deaths in the same year. It also has the fifth-highest incidence rate among cancers, with 5.7% of new cancer cases being of this type. Detection of cancer in its early stages is crucial for prolonging the life of a patient.Growing Pressure on Countries to Increase Healthcare Expenditure to Prove Conducive for GrowthIn recent years, there has been mounting pressure on countries, especially developing economies, to improve their healthcare infrastructure through increased spending. According to the WHO, in 2016, global expenditure on health was around USD 7.5 trillion, roughly 10% of world GDP. Of more import is the fact that the rise in healthcare spending was faster in low and middle-income countries than in developed countries, the WHO points out.
Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/endoscopy-ultrasound-market-100558
This shows that countries are ready to spend on modern diagnostic devices and machines to raise public health levels. EUS products require higher spending capacity from both producers and consumers and with government support and a simultaneous rise in incomes, this equipment can be made accessible to majority of the people. This can significantly expand the market, create new avenues for revenue generation, and pave the way for more innovations.High Prevalence of Chronic Digestive Disorders to Propel the Market in North AmericaWith a revenue generation of USD 296.9 Million in 2018, North America is set to occupy a commanding position in the EUS market till 2026. This is mainly owing to the high incidence rate of chronic digestive diseases among the geriatric population in the US, leading to the performance of around 18 million endoscopy procedures in the US, as per NCBI estimates.Well-established healthcare systems and proactive healthcare policies are factors that will fuel the market in Europe. In Asia-Pacific, increasing prevalence of cancer is expected to push up the demand for echo-endoscopy equipment, which augurs well for this market.
Quick Buy –  Endoscopic Ultrasound Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100558
Increasing Investment in R&D Activities to Intensify CompetitionMajor players are ramping up their investment in research and development to come out with novel products in a bid to diversify their product offerings as well as strengthen their position in the market. For example, in October 2019, Fujifilm Medical Systems launched eight new endoscopes along with a complete suite of Endoscopy Imaging Solutions in San Antonio, Texas. Similarly, in March 2019, ESAOTE unveiled its high-performance ultrasound product line for hospitals called MyLab X8.List of the key companies in the endoscopic ultrasound market:Olympus CorporationPENTAX MedicalFUJIFILM Holdings CorporationCook MedicalBoston Scientific CorporationMedtronicMedi-Globe GmbHCONMED Corporation
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/endoscopic-ultrasound-market-100558
Global Endoscopic Ultrasound Market Segmentations:By Product•              Endoscopeso              Radial Endoscopeso              Linear Endoscopes•              Ultrasound Probes•              Ultrasonic Processors•              Imaging Systems•              Needles•              AccessoriesBy Application•              Oncology•              Pancreatic Conditions•              OthersBy End User•              Hospitals•              Ambulatory Surgery Centers•              OthersBy Geography•              North America (U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)•              Latin America (Brazil, Mexico, and Rest of Latin America)•              The Middle East and Africa (South Africa, GCC, and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/endoscopic-ultrasound-market-100558
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:Human Insulin Market Share & Industry Analysis, By Type (Analogue Insulin, Traditional Human Insulin), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Regional Forecast, 2019-2026Influenza Vaccine Market Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2019-2026Autotransfusion Devices Market Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2019-2026Trauma Implants Market Share & Industry Analysis, By Product (Metal Plates & Screws, Pins/Wires, Nails & Rods, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026Idiopathic Inflammatory Myopathy Treatment Market Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/endoscopic-ultrasound-eus-market-9390

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.